APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bicyclic Peptide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bicyclic Peptide Market Outlook and Growth Opportunities 2026

30 December 2025191 pages

Choose your research edition.

Industry ResearchBicyclic Peptide Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Bicyclic Peptide Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Bicyclic Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bicyclic Peptide Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Bicyclic Peptide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Bicyclic Peptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bicyclic Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bicyclic Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bicyclic Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bicyclic Peptide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bicyclic Peptide market include Creative Peptides, Genscript, JPT Peptide Technologies and Hongtide, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bicyclic Peptide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bicyclic Peptide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bicyclic Peptide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bicyclic Peptide market size, projected growth trends, production technologies, key applications, and end-use industries.

Bicyclic Peptide Segment by Company

Creative Peptides

Genscript

JPT Peptide Technologies

Hongtide

Bicyclic Peptide Segment by Type

Heterocyclic Bicyclic Peptides

Homocyclic Bicyclic Peptides

Bicyclic Peptide Segment by Application

Neurogenic Activity

Antibacterial

Antitumor

Other

Bicyclic Peptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Bicyclic Peptide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bicyclic Peptide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bicyclic Peptide significant trends, drivers, influence factors in global and regions.

6. To analyze Bicyclic Peptide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bicyclic Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bicyclic Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bicyclic Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bicyclic Peptide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bicyclic Peptide industry.

Chapter 3: Detailed analysis of Bicyclic Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bicyclic Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bicyclic Peptide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bicyclic Peptide Industry Trends Table 2. Bicyclic Peptide Industry Drivers Table 3. Bicyclic Peptide Industry Opportunities and Challenges Table 4. Bicyclic Peptide Industry Restraints Table 5. Global Bicyclic Peptide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bicyclic Peptide Revenue Share by Company (2021-2026) Table 7. Global Bicyclic Peptide Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Bicyclic Peptide Sales Volume Share by Company (2021-2026) Table 9. Global Bicyclic Peptide Average Price (US$/g) of Company (2021-2026) Table 10. Global Bicyclic Peptide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bicyclic Peptide Key Company Manufacturing Base & Headquarters Table 12. Global Bicyclic Peptide Company, Product Type & Application Table 13. Global Bicyclic Peptide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bicyclic Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Heterocyclic Bicyclic Peptides Table 18. Significant Companies of Homocyclic Bicyclic Peptides Table 19. Global Bicyclic Peptide Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Bicyclic Peptide Sales Volume by Type (2021-2026) & (Kg) Table 21. Global Bicyclic Peptide Sales Volume by Type (2027-2032) & (Kg) Table 22. Global Bicyclic Peptide Sales Volume Share by Type (2021-2026) Table 23. Global Bicyclic Peptide Sales Volume Share by Type (2027-2032) Table 24. Global Bicyclic Peptide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bicyclic Peptide Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bicyclic Peptide Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bicyclic Peptide Sales Value Share by Type (2021-2026) Table 28. Global Bicyclic Peptide Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Neurogenic Activity Table 30. Significant Companies of Antibacterial Table 31. Significant Companies of Antitumor Table 32. Significant Companies of Other Table 33. Global Bicyclic Peptide Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global Bicyclic Peptide Sales Volume by Application (2021-2026) & (Kg) Table 35. Global Bicyclic Peptide Sales Volume by Application (2027-2032) & (Kg) Table 36. Global Bicyclic Peptide Sales Volume Share by Application (2021-2026) Table 37. Global Bicyclic Peptide Sales Volume Share by Application (2027-2032) Table 38. Global Bicyclic Peptide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Bicyclic Peptide Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Bicyclic Peptide Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Bicyclic Peptide Sales Value Share by Application (2021-2026) Table 42. Global Bicyclic Peptide Sales Value Share by Application (2027-2032) Table 43. Global Bicyclic Peptide Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global Bicyclic Peptide Sales by Region (2021-2026) & (Kg) Table 45. Global Bicyclic Peptide Sales Market Share by Region (2021-2026) Table 46. Global Bicyclic Peptide Sales by Region (2027-2032) & (Kg) Table 47. Global Bicyclic Peptide Sales Market Share by Region (2027-2032) Table 48. Global Bicyclic Peptide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Bicyclic Peptide Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Bicyclic Peptide Sales Value Share by Region (2021-2026) Table 51. Global Bicyclic Peptide Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Bicyclic Peptide Sales Value Share by Region (2027-2032) Table 53. Global Bicyclic Peptide Market Average Price (US$/g) by Region (2021-2026) Table 54. Global Bicyclic Peptide Market Average Price (US$/g) by Region (2027-2032) Table 55. Global Bicyclic Peptide Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global Bicyclic Peptide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 58. Global Bicyclic Peptide Sales Market Share by Country (2021-2026) Table 59. Global Bicyclic Peptide Sales by Country (2027-2032) & (Kg) Table 60. Global Bicyclic Peptide Sales Market Share by Country (2027-2032) Table 61. Global Bicyclic Peptide Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Bicyclic Peptide Sales Value Market Share by Country (2021-2026) Table 63. Global Bicyclic Peptide Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Bicyclic Peptide Sales Value Market Share by Country (2027-2032) Table 65. Creative Peptides Company Information Table 66. Creative Peptides Business Overview Table 67. Creative Peptides Bicyclic Peptide Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 68. Creative Peptides Bicyclic Peptide Product Portfolio Table 69. Creative Peptides Recent Development Table 70. Genscript Company Information Table 71. Genscript Business Overview Table 72. Genscript Bicyclic Peptide Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 73. Genscript Bicyclic Peptide Product Portfolio Table 74. Genscript Recent Development Table 75. JPT Peptide Technologies Company Information Table 76. JPT Peptide Technologies Business Overview Table 77. JPT Peptide Technologies Bicyclic Peptide Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 78. JPT Peptide Technologies Bicyclic Peptide Product Portfolio Table 79. JPT Peptide Technologies Recent Development Table 80. Hongtide Company Information Table 81. Hongtide Business Overview Table 82. Hongtide Bicyclic Peptide Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 83. Hongtide Bicyclic Peptide Product Portfolio Table 84. Hongtide Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Bicyclic Peptide Distributors List Table 88. Bicyclic Peptide Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Bicyclic Peptide Product Image Figure 2. Global Bicyclic Peptide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bicyclic Peptide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bicyclic Peptide Sales (2021-2032) & (Kg) Figure 5. Global Bicyclic Peptide Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Bicyclic Peptide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Heterocyclic Bicyclic Peptides Image Figure 10. Homocyclic Bicyclic Peptides Image Figure 11. Global Bicyclic Peptide Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Bicyclic Peptide Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bicyclic Peptide Sales Volume Share by Type (2021-2032) Figure 14. Global Bicyclic Peptide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bicyclic Peptide Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bicyclic Peptide Sales Value Share by Type (2021-2032) Figure 17. Neurogenic Activity Image Figure 18. Antibacterial Image Figure 19. Antitumor Image Figure 20. Other Image Figure 21. Global Bicyclic Peptide Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Bicyclic Peptide Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Bicyclic Peptide Sales Volume Share by Application (2021-2032) Figure 24. Global Bicyclic Peptide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Bicyclic Peptide Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Bicyclic Peptide Sales Value Share by Application (2021-2032) Figure 27. Global Bicyclic Peptide Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Bicyclic Peptide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Bicyclic Peptide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Bicyclic Peptide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Bicyclic Peptide Sales Value (2021-2032) & (US$ Million) Figure 32. North America Bicyclic Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Bicyclic Peptide Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Bicyclic Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Bicyclic Peptide Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Bicyclic Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Bicyclic Peptide Sales Value (2021-2032) & (US$ Million) Figure 38. South America Bicyclic Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Bicyclic Peptide Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Bicyclic Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Bicyclic Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Bicyclic Peptide Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Bicyclic Peptide Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Heterocyclic Bicyclic Peptides
  • Homocyclic Bicyclic Peptides
Applications
  • Neurogenic Activity
  • Antibacterial
  • Antitumor
  • Other
Companies covered
  • Creative Peptides
  • Genscript
  • JPT Peptide Technologies
  • Hongtide

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bicyclic Peptide Sales Value (2021-2032)
  4. 1.2.2 Global Bicyclic Peptide Sales Volume (2021-2032)
  5. 1.2.3 Global Bicyclic Peptide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bicyclic Peptide Market Dynamics
  1. 2.1 Bicyclic Peptide Industry Trends
  2. 2.2 Bicyclic Peptide Industry Drivers
  3. 2.3 Bicyclic Peptide Industry Opportunities and Challenges
  4. 2.4 Bicyclic Peptide Industry Restraints
3 Bicyclic Peptide Market by Company
  1. 3.1 Global Bicyclic Peptide Company Revenue Ranking in 2025
  2. 3.2 Global Bicyclic Peptide Revenue by Company (2021-2026)
  3. 3.3 Global Bicyclic Peptide Sales Volume by Company (2021-2026)
  4. 3.4 Global Bicyclic Peptide Average Price by Company (2021-2026)
  5. 3.5 Global Bicyclic Peptide Company Ranking (2024-2026)
  6. 3.6 Global Bicyclic Peptide Company Manufacturing Base and Headquarters
  7. 3.7 Global Bicyclic Peptide Company Product Type and Application
  8. 3.8 Global Bicyclic Peptide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bicyclic Peptide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bicyclic Peptide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bicyclic Peptide Market by Type
  1. 4.1 Bicyclic Peptide Type Introduction
  2. 4.1.1 Heterocyclic Bicyclic Peptides
  3. 4.1.2 Homocyclic Bicyclic Peptides
  4. 4.2 Global Bicyclic Peptide Sales Volume by Type
  5. 4.2.1 Global Bicyclic Peptide Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bicyclic Peptide Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bicyclic Peptide Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bicyclic Peptide Sales Value by Type
  9. 4.3.1 Global Bicyclic Peptide Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bicyclic Peptide Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bicyclic Peptide Sales Value Share by Type (2021-2032)
5 Bicyclic Peptide Market by Application
  1. 5.1 Bicyclic Peptide Application Introduction
  2. 5.1.1 Neurogenic Activity
  3. 5.1.2 Antibacterial
  4. 5.1.3 Antitumor
  5. 5.1.4 Other
  6. 5.2 Global Bicyclic Peptide Sales Volume by Application
  7. 5.2.1 Global Bicyclic Peptide Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bicyclic Peptide Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Bicyclic Peptide Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Bicyclic Peptide Sales Value by Application
  11. 5.3.1 Global Bicyclic Peptide Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Bicyclic Peptide Sales Value by Application (2021-2032)
  13. 5.3.3 Global Bicyclic Peptide Sales Value Share by Application (2021-2032)
6 Bicyclic Peptide Regional Sales and Value Analysis
  1. 6.1 Global Bicyclic Peptide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bicyclic Peptide Sales by Region (2021-2032)
  3. 6.2.1 Global Bicyclic Peptide Sales by Region: 2021-2026
  4. 6.2.2 Global Bicyclic Peptide Sales by Region (2027-2032)
  5. 6.3 Global Bicyclic Peptide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bicyclic Peptide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bicyclic Peptide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bicyclic Peptide Sales Value by Region (2027-2032)
  9. 6.5 Global Bicyclic Peptide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bicyclic Peptide Sales Value (2021-2032)
  12. 6.6.2 North America Bicyclic Peptide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bicyclic Peptide Sales Value (2021-2032)
  15. 6.7.2 Europe Bicyclic Peptide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bicyclic Peptide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bicyclic Peptide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bicyclic Peptide Sales Value (2021-2032)
  21. 6.9.2 South America Bicyclic Peptide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bicyclic Peptide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bicyclic Peptide Sales Value Share by Country, 2025 VS 2032
7 Bicyclic Peptide Country-level Sales and Value Analysis
  1. 7.1 Global Bicyclic Peptide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bicyclic Peptide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bicyclic Peptide Sales by Country (2021-2032)
  4. 7.3.1 Global Bicyclic Peptide Sales by Country (2021-2026)
  5. 7.3.2 Global Bicyclic Peptide Sales by Country (2027-2032)
  6. 7.4 Global Bicyclic Peptide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bicyclic Peptide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bicyclic Peptide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bicyclic Peptide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bicyclic Peptide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bicyclic Peptide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Creative Peptides
  2. 8.1.1 Creative Peptides Company Information
  3. 8.1.2 Creative Peptides Business Overview
  4. 8.1.3 Creative Peptides Bicyclic Peptide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Creative Peptides Bicyclic Peptide Product Portfolio
  6. 8.1.5 Creative Peptides Recent Developments
  7. 8.2 Genscript
  8. 8.2.1 Genscript Company Information
  9. 8.2.2 Genscript Business Overview
  10. 8.2.3 Genscript Bicyclic Peptide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Genscript Bicyclic Peptide Product Portfolio
  12. 8.2.5 Genscript Recent Developments
  13. 8.3 JPT Peptide Technologies
  14. 8.3.1 JPT Peptide Technologies Company Information
  15. 8.3.2 JPT Peptide Technologies Business Overview
  16. 8.3.3 JPT Peptide Technologies Bicyclic Peptide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 JPT Peptide Technologies Bicyclic Peptide Product Portfolio
  18. 8.3.5 JPT Peptide Technologies Recent Developments
  19. 8.4 Hongtide
  20. 8.4.1 Hongtide Company Information
  21. 8.4.2 Hongtide Business Overview
  22. 8.4.3 Hongtide Bicyclic Peptide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hongtide Bicyclic Peptide Product Portfolio
  24. 8.4.5 Hongtide Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bicyclic Peptide Value Chain Analysis
  2. 9.1.1 Bicyclic Peptide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bicyclic Peptide Sales Mode & Process
  6. 9.2 Bicyclic Peptide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bicyclic Peptide Distributors
  9. 9.2.3 Bicyclic Peptide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst